Financial results - IBORMED S.R.L.

Financial Summary - Ibormed S.r.l.
Unique identification code: 32351557
Registration number: J14/224/2013
Nace: 2521
Sales - Ron
97.769
Net Profit - Ron
53.966
Employee
1
The most important financial indicators for the company Ibormed S.r.l. - Unique Identification Number 32351557: sales in 2023 was 97.769 euro, registering a net profit of 53.966 euro and having an average number of 1 employees. Firma isi desfasoara activitatea in domeniul Productia de radiatoare si cazane pentru incalzire centrala having the NACE code 2521.

Sales, Profit, Employees, Debts, Capitals, Financial Results - Ibormed S.r.l.

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Sales - EUR 54.304 62.616 0 13.604 29.549 30.978 19.741 30.487 92.437 97.769
Total Income - EUR 54.542 64.046 0 17.603 27.649 31.272 19.747 30.487 92.437 97.778
Total Expenses - EUR 49.308 56.948 322 18.479 24.294 14.241 14.390 16.301 37.837 42.854
Gross Profit/Loss - EUR 5.235 7.098 -322 -875 3.354 17.031 5.357 14.186 54.600 54.924
Net Profit/Loss - EUR 3.605 5.213 -322 -1.011 2.873 16.178 4.833 13.451 52.936 53.966
Employees 3 3 1 2 2 1 1 0 1 1
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded. In the last year of activity, the sales increased by 6.1%, from 92.437 euro in the year 2022, to 97.769 euro in 2023. The Net Profit increased by 1.190 euro, from 52.936 euro in 2022, to 53.966 in the last year.

Check the financial reports for the company - Ibormed S.r.l.

Rating financiar

Financial Rating -
Ibormed S.r.l.

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Check Financial Rating
Limite de plata

Payment Limits -
Ibormed S.r.l.

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Ibormed S.r.l.

It determines the risk of insolvency based on the submitted accounting balance.

Check Insolvency Probability
Rapoarte financiare

Financial Reports -
Ibormed S.r.l.

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Ibormed S.r.l. - CUI 32351557

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Fixed Assets 23 24 23 1.914 1.552 1.200 862 535 1.376 924
Current Assets 10.593 11.417 11.030 13.180 12.597 28.464 33.387 25.254 57.569 63.860
Inventories 0 0 0 5.147 698 0 0 0 2.875 1.625
Receivables 3.266 0 64 3.830 1.642 2.646 5.193 4.702 8.417 56.848
Cash 7.327 11.417 10.966 4.203 10.257 25.818 28.194 20.552 46.277 5.387
Shareholders Funds 5.693 10.953 10.519 9.330 12.032 27.977 32.280 14.437 53.223 54.016
Social Capital 45 45 45 44 43 42 41 40 41 40
Debts 4.923 488 534 5.764 2.558 2.120 2.394 11.767 6.132 11.176
Income in Advance 0 0 0 0 0 0 0 0 6 6
Exchange rate - RON 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445 4.4821
Main CAEN "2521 - 2521"
CAEN Financial Year 4120
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 63.860 euro in 2023 which includes Inventories of 1.625 euro, Receivables of 56.848 euro and cash availability of 5.387 euro.
The company's Equity was valued at 54.016 euro, while total Liabilities amounted to 11.176 euro. Equity increased by 954 euro, from 53.223 euro in 2022, to 54.016 in 2023. The Debt Ratio was 17.1% in the year 2023.

Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.

Subscriptions Financial Reports

You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.

Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!

Reviews - Ibormed S.r.l.

Comments - Ibormed S.r.l.

Similar services useful for checking companies and business development.

Contacts Firms

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Company Lists

Create lists of companies for your sales activity according to your own criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.